News

ISB Spotlight: Lisa Iype

Dr. Lisa Iype (Ilya Shmulevich group) has been promoted to Senior Bioinformatics Scientist. She has experience in biochemistry, software and website development, and data analysis. She works with high-dimensional cancer data sets and looks for significant patterns which may provide insight into cancer development and progression. Dr. Shmulevich commented: “Lisa has made major contributions to The Cancer Genome Atlas project through her participation in tumor working groups, including thyroid carcinoma and prostate cancer, and her leadership role in the development of Regulome Explorer as a research tool in cancer genomics.” Congratulations to Lisa.

Recent Articles

  • Cultivated meat illustration

    How Systems Biology Is Helping Advance the Cultivated Meat Industry

    The quest to create cultivated meat has been a true multidisciplinary puzzle. It’s biology, engineering, physics, bioinformatics, mathematics, computer science, and more. Enter systems biology. ISB and other organizations are toiling to better understand how to create lab-grown meat in a safe, effective manner that can eventually scale up to compete with traditional meat.

  • 2021 Innovator Awards

    Three Collaborative Projects Announced for ISB’s 2021 Innovator Award Program

    ISB has kicked off the fifth year of its Innovator Award Program by announcing three collaborative and cross-disciplinary projects. The program was created in 2017 to support early-career scientists working on high-risk, high-reward innovations, and champions interdisciplinary collaboration for non-faculty ISB researchers.

  • CRI iAtlas

    CRI iAtlas Expands to Interactive Analysis of Data on Immunotherapy Treatments

    CRI iAtlas is a comprehensive web-based resource that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenvironment. The iAtlas team released immuno-oncology modules that allow investigators to access and work with genomics data from trials of treatment with immune-checkpoint inhibitors.